Emerging evidence implicates the ATP/GTP-binding protein-like 4 gene (AGBL4) in various pathological processes, including antituberculosis drug-induced hepatotoxicity (7), cardiometabolic risk (8), and colorectal cancer, where it is anticipated to serve as a novel biomarker (9). Here, AGBL4 is linked to colorectal cancer.